Peri‐transfusion quality‐of‐life assessment for patients with myelodysplastic syndromes-Reference-Cited by-同舟云学术

Peri‐transfusion quality‐of‐life assessment for patients with myelodysplastic syndromes

Published:2021-07-12 Issue:10 Volume:61 Page:2830-2836
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Abel Gregory A.¹^ORCID,Klepin Heidi D.²,Magnavita Emily S.¹,Jaung Tim¹,Lu Wen³,Shallis Rory M.⁴,Hantel Andrew¹,Bahl Nupur E.¹,Dellinger‐Johnson Rebecca²,Winer Eric S.¹,Zeidan Amer M.⁴

Affiliation:

1. Division of Population Sciences, Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA

2. Department of Internal Medicine, Section on Hematology and Oncology Wake Forest Baptist Comprehensive Cancer Center Winston‐Salem North Carolina USA

3. Division of Transfusion Medicine, Department of Pathology Brigham and Women's Hospital Boston Massachusetts USA

4. Department of Internal Medicine, Section of Hematology Yale Cancer Center New Haven Connecticut USA

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16584

Reference17 articles.

1. Myelodysplastic syndromes

2. Costs and quality of life in patients with myelodysplastic syndromes;Lucioni C;Am J Blood Res,2013

3. Quality of life and use of red cell transfusion in patients with myelodysplastic syndromes. A systematic review

4. Transfusion independence in patients with myelodysplastic syndromes

5. The deleterious effects of iron overload in patients with myelodysplastic syndromes

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS);HemaSphere;2024-05

2. Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE;Transfusion;2024-02

4. Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review;Blood Reviews;2023-09

5. Supportive Care for Patients With Myelodysplastic Syndromes;The Cancer Journal;2023-05